PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

I find the financials in the MST Access report baffling as well....

  1. 6,512 Posts.
    lightbulb Created with Sketch. 1912
    I find the financials in the MST Access report baffling as well.

    How can income in the 2020F be $61m, then drop to $6m in 2020, then jump to $92m in 2022?

    It's useless to me without an explanation of how they came to the figures.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.